Recent studies have reported that APOBEC3B-associated mutagenic agents have an effect on the evolution of various cancer types and it is significantly overexpressed in a variety of cancers (such as breast, gastric, lung, and ovarian) compared to corresponding normal tissues [8, 17, 18]. This evidence concerns the gene APOBEC3B and cancer.